CD133, one of the markers of cancer stem cells in Hep-2 cell line

Laryngoscope

Volumn 117, Issue 3, 2007, Pages 455-460

  Zhou, Liang ^a   Wei, Xudong ^a,b   Cheng, Lei ^a   Tian, Jie ^a   Jiang, Jack J ^a  

^a FUDAN UNIVERSITY   (China)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Cancer stem cell; Hep 2 cell

Indexed keywords

BIOLOGICAL MARKER; CD133 ANTIGEN;

ANTIGEN EXPRESSION; ARTICLE; CANCER STEM CELL; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL ISOLATION; CELL LINEAGE; CELL PROLIFERATION; CONTROLLED STUDY; FLOW CYTOMETRY; HEP 2 CELL; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOMAGNETIC SEPARATION; IN VITRO STUDY; PRIORITY JOURNAL;

ANTIGENS, CD; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; FLOW CYTOMETRY; GLYCOPROTEINS; HUMANS; LARYNGEAL NEOPLASMS; MICROSCOPY, FLUORESCENCE; PEPTIDES; TUMOR MARKERS, BIOLOGICAL; TUMOR STEM CELLS;

EID: 33947095683     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.mlg.0000251586.15299.35     Document Type: Article

References (23)

1. Hamburger AW, Salmon SE. Primary bioassay of human tumor stem cells. Science 1977;197:461-463.
2. Singh SK, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003;63:5821-5828.
3. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111.
4. Finlan LE, Hupp TR. Epidermal stem cells and cancer stem cells: Insights into cancer and potential therapeutic strategies. Eur J Cancer 2006;42:1283-1292.
5. Bonnet D, Dick J. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730-737.
6. Singh SK, Clarke ID, Hide T, et al. Cancer stem cells in nervous system tumors. Oncogene 2004;23:7267-7273.
7. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003;100:3983-3988.
8. Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res 2005;65:5506-5511.
9. Yin AH, Miraglia S, Zanjani ED, et al. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood 1997;90:5002-5012.
10. Peichev M, Naiyer AJ, Pereira D, et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000;95:952-958.
11. Uchida N, Buck DW, He D, et al. Direct isolation of human central nervous system stem cells. Proc Natl Acad Sci U S A 2000;97:14720-14725.
12. Corbeil D, Roper K, Hellwig A, et al. The human AC133 hematopoietic stem cell antigen is also expressed in epithelial cells and targeted to plasma membrane protrusions. J Biol Chem 2000;275:5512-5520.
13. Weigmann A, Corbei D, Hellwig A, et al. Prominin, a novemicrovilli- specific polytopic membrane protein of the apical surface of epithelial cells, is targeted to plasmalemmal protrusions of non-epithelial cells. Proc Natl Acad Sci U S A 1997;94:12425-12430.
14. + prostate cancer stem cell from human tumors are highly tumorigenic in vivo. Eur Urol Suppl 2006;5:790.
15. Richardson GD, Robson CN, Lang SH, et al. CD133, a novel marker for human prostatic epithelial stem cells. J Cell Sci 2004;117:3539-3545.
16. Collins AT, Berry PA, Hyde C, et al. Prospective identification of tumorigenic prostate cancer stem cells. Cancer Res 2005;65:10946-10951.
17. Rizzo S, Attard G, Hudson DL. Prostate epithelial stem cells. Cell Prolif 2005;38:363-374.
18. Pilkington GJ. Cancer stem cells in the mammalian central nervous system. Cell Prolif 2005;38:423-433.
19. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004;432:396-401.
20. Bender Kim CF, Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cell in normal lung and lung cancer. Cell 2005;121:811-813.
21. Heidt DG, Li C, Mollenberg N, et al. identification of pancreatic cancer stem cells. J Surg Res 2006;130:194-195.
22. Al-Hajj M, Becker MW, Wicha M, et al. Therapeutic implication of cancer stem cells. Curr Opin Genet Dev 2004;14:43-47.
23. Burkert J, Wright NA, Alsion MR, et al. Cancer stem cells: opportunities for novel diagnostics and drug discovery. Eur J Cancer 2006;42:1195-1196.